Cosmos Health (NASDAQ: COSM) — Company Overview, News & Financial Data
Cosmos Health develops and distributes pharmaceuticals globally, focusing on improving healthcare affordability and access.
Cosmos Health
Cosmos Health (NASDAQ:COSM) is a dynamic healthcare company committed to improving patient outcomes through the development and distribution of high-quality pharmaceuticals and healthcare products globally. Cosmos Health is traded exclusively on the NASDAQ under the ticker symbol COSM. Central to its operations, the company focuses on a broad portfolio that includes both proprietary and generic medications, addressing a wide range of health conditions to meet diverse patient needs. Its projects range from research and development in cutting-edge pharmaceuticals to strategic partnerships aimed at enhancing global access to essential medicines. Cosmos Health's overarching objectives are centered on driving innovation in healthcare, expanding its market presence, and delivering sustainable growth by improving healthcare affordability and accessibility worldwide.
Snapshot
Operations
Products and/or services of Cosmos Health
- Comprehensive healthcare solutions integrating advanced diagnostics and personalized treatment plans.
- Pharmaceutical distribution network ensuring efficient delivery of essential medications globally.
- Innovative medical devices facilitating advanced patient care and diagnostics.
- Digital health platforms for remote monitoring and patient engagement.
- Research and development in cutting-edge pharmaceuticals and therapies.
- Community health programs focused on preventive care and education.
Cosmos Health executive team
- Grigorios SiokasChairman & CEO
- Georgios TerzisChief Financial Officer
- Nikolaos BardakisChief Operating Officer
- Demetrios G. DemetriadesSecretary & Independent Director
- Dimitrios TrafalisHead of Oncology
Latest news about Cosmos Health
Cosmos Health forecasts $15 million U.S. sales
United StatesCosmos Health reports preliminary $54.3 million nine-month revenue
United StatesCosmos Health’s CosmoFarm reports record Q2 2026 revenue above $15 million
United StatesCosmos Health reports $20 million contract pipeline
United StatesCosmos Health signs Saudi supplement deal
United StatesCosmos Health revenue expands 29% to $18.99 million
United States
Key financials
Reported results for Cosmos Health, in USD.
- Market cap
- 27.9M
- Revenue (TTM)
- 73.7M
- P/E ratio
- —
- EPS (diluted, TTM)
- -0.7
- Dividend yield
- —
- Profit margin
- -33.1%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 65.3M | -16.5M | -19.1M | |
| 54.4M | -15.5M | -16.2M | |
| 53.4M | -21.8M | -18.5M | |
| 50.3M | -7.5M | -13.8M |